Tenax Therapeutics, Inc. SEC filings TENX

Tenax Therapeutics, Inc. has 995 filings in SEC EDGAR's recent list, going back to Aug 2, 1996. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Tenax Therapeutics, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration May 12, 2026 —
S-3 Shelf registration Mar 24, 2026 —
424B3 Prospectus Apr 23, 2025 —
S-3 Shelf registration Apr 15, 2025 —
S-8 Employee stock plan registration Nov 26, 2024 —
424B3 Prospectus Sep 12, 2024 —
S-8 Employee stock plan registration Aug 30, 2024 —
S-3 Shelf registration Aug 30, 2024 —
POS AM Form pos am Apr 11, 2024 —
POS AM Form pos am Apr 11, 2024 —
424B3 Prospectus Feb 26, 2024 —
424B3 Prospectus Feb 26, 2024 —
424B3 Prospectus Feb 21, 2024 —
424B3 Prospectus Feb 21, 2024 —
424B3 Prospectus Feb 13, 2024 —
424B4 Prospectus Feb 9, 2024 —
424B3 Prospectus Feb 8, 2024 —
424B3 Prospectus Feb 6, 2024 —
S-1/A Amended registration statement Feb 2, 2024 —
S-1/A Amended registration statement Feb 1, 2024 —
424B3 Prospectus Jan 22, 2024 —
424B3 Prospectus Jan 16, 2024 —
424B3 Prospectus Jan 9, 2024 —
424B3 Prospectus Dec 1, 2023 —
S-1 Registration statement Dec 1, 2023 —
424B3 Prospectus Nov 14, 2023 —
424B3 Prospectus Aug 15, 2023 —
424B3 Prospectus Jul 20, 2023 —
424B3 Prospectus Jun 14, 2023 —
424B3 Prospectus Jun 1, 2023 —
424B3 Prospectus Apr 13, 2023 —
424B3 Prospectus Apr 4, 2023 —
424B4 Prospectus Feb 6, 2023 —
S-1MEF Form s-1mef Feb 2, 2023 —
S-1/A Amended registration statement Jan 31, 2023 —
S-1 Registration statement Jan 23, 2023 —
S-8 Employee stock plan registration Aug 12, 2022 —
424B3 Prospectus Jun 3, 2022 —
S-3 Shelf registration May 25, 2022 —
S-8 Employee stock plan registration Sep 2, 2021 —
424B3 Prospectus Sep 2, 2021 —
S-3 Shelf registration Aug 20, 2021 —
424B3 Prospectus Oct 1, 2020 —
S-3/A Primary document Sep 11, 2020 —
S-3 Shelf registration Aug 20, 2020 —
424B5 Prospectus supplement Jul 8, 2020 —
424B5 Prospectus supplement Mar 13, 2020 —
S-8 Employee stock plan registration Aug 30, 2019 —
424B4 Prospectus Dec 7, 2018 —
S-1/A Amended registration statement Dec 6, 2018 —
S-1/A Amended registration statement Dec 3, 2018 —
FWP Free writing prospectus Nov 20, 2018 —
S-1/A Amended registration statement Nov 20, 2018 —
S-1 Registration statement Nov 6, 2018 —
S-3 Shelf registration May 15, 2018 —
S-8 Employee stock plan registration Apr 3, 2018 —
S-8 Employee stock plan registration Mar 14, 2016 —
S-3 Shelf registration Feb 24, 2015 —
POS AM Filing Aug 22, 2014 —
S-3 Shelf registration Jun 2, 2014 —
S-8 Employee stock plan registration Jun 2, 2014 —
424B3 Prospectus Apr 14, 2014 —
424B3 Prospectus Mar 24, 2014 —
424B3 Prospectus Mar 24, 2014 —
424B5 Prospectus supplement Mar 18, 2014 —
424B5 Prospectus supplement Mar 17, 2014 —
424B3 Prospectus Mar 10, 2014 —
424B3 Prospectus Jan 28, 2014 —
424B3 Prospectus Dec 30, 2013 —
424B3 Prospectus Dec 27, 2013 —
424B3 Prospectus Dec 18, 2013 —
424B3 Prospectus Dec 16, 2013 —
424B3 Prospectus Nov 26, 2013 —
424B3 Prospectus Nov 14, 2013 —
424B3 Prospectus Nov 1, 2013 —
424B3 Prospectus Oct 15, 2013 —
S-3 Shelf registration Oct 4, 2013 —
424B3 Prospectus Sep 19, 2013 —
424B3 Prospectus Sep 18, 2013 —
424B3 Prospectus Aug 30, 2013 —
424B3 Prospectus Aug 29, 2013 —
424B3 Prospectus Aug 14, 2013 —
424B3 Prospectus Jul 31, 2013 —
424B3 Prospectus Jul 25, 2013 —
424B1 Filing Jul 22, 2013 —
S-1/A Amended registration statement Jul 18, 2013 —
S-1/A Amended registration statement Jul 17, 2013 —
S-1/A Amended registration statement Jul 5, 2013 —
FWP Free writing prospectus Jun 28, 2013 —
S-1/A Amended registration statement Jun 27, 2013 —
424B3 Prospectus Apr 17, 2013 —
S-3 Shelf registration Apr 12, 2013 —
S-1 Registration statement Mar 22, 2013 —
S-3 Shelf registration Mar 21, 2013 —
424B5 Prospectus supplement Feb 22, 2013 —
424B5 Prospectus supplement Dec 9, 2011 —
S-8 Employee stock plan registration May 28, 2010 —
424B5 Prospectus supplement May 4, 2010 —
424B5 Prospectus supplement May 4, 2010 —
S-3/A Form s-3 amendment #1 Apr 7, 2010 —
S-3 Shelf registration Mar 26, 2010 —
S-1 Registration statement Oct 14, 2008 —
424B3 Prospectus Jul 27, 2007 —
424B3 Prospectus Jun 27, 2007 —
424B3 Prospectus May 25, 2007 —
424B3 Prospectus Apr 26, 2007 —
424B3 Prospectus Mar 27, 2007 —
424B3 Prospectus Feb 26, 2007 —
424B3 Prospectus Jan 31, 2007 —
424B3 Prospectus Dec 27, 2006 —
424B3 Prospectus Nov 28, 2006 —
424B3 Prospectus Oct 25, 2006 —
424B3 Prospectus Sep 28, 2006 —
424B3 Prospectus Aug 29, 2006 —
424B3 Prospectus Aug 10, 2006 —
POS AM Post-effective amendment no.1 on form s-1 to form s-2 Aug 3, 2006 —
424B3 Prospectus Jul 26, 2006 —
424B3 Prospectus Jun 27, 2006 —
424B3 Prospectus May 26, 2006 —
424B3 Prospectus Apr 26, 2006 —
424B3 Prospectus Mar 24, 2006 —
424B3 Prospectus Mar 20, 2006 —
424B3 Prospectus Mar 20, 2006 —
424B3 Prospectus Feb 24, 2006 —
424B3 Prospectus Jan 27, 2006 —
424B3 Prospectus Dec 30, 2005 —
424B3 Prospectus Dec 16, 2005 —
424B3 Prospectus Dec 16, 2005 —
424B3 Prospectus Nov 28, 2005 —
424B3 Prospectus Oct 28, 2005 —
424B3 Prospectus Sep 27, 2005 —
424B3 Prospectus Sep 27, 2005 —
424B3 Prospectus Aug 26, 2005 —
424B3 Prospectus Aug 26, 2005 —
POS AM Post effective amendment no. 1 Aug 15, 2005 —
S-2 Form s-2 Aug 15, 2005 —
424B3 Prospectus Jan 28, 2005 —
S-2 Form s-2 registration statement Jan 14, 2005 —
424B3 Prospectus Sep 10, 2004 —
S-2 Form s-2 for synthetic blood international, inc. Sep 2, 2004 —
S-1 Registration statement Aug 31, 2001 —

Showing 141 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TENX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Chapel Hill, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
34956
Former names
OXYGEN BIOTHERAPEUTICS, INC. (until Sep 15, 2014); SYNTHETIC BLOOD INTERNATIONAL INC (until Jun 30, 2008)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.